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Effects of current smoking and smoking discontinuation on Increasing evidence suggests that chronic smoking is
renal function and proteinuria in the general population. a risk factor for the progression of nephropathies [1].
Background. Smoking may adversely affect the progression Smoking was implicated in all aspects of the progressionof renal diseases. However, it is unknown whether smoking
of renal disease in type 1 diabetics, as it increases theaffects renal function in subjects without nephropathy.
Methods. In 1998, 28,409 volunteers from the general popu- risk of microalbuminuria and accelerates the rate of pro-
lation were examined at the Institut Re´gional pour la Sante´ gression from microalbuminuria to proteinuria and sub-
(IRSA). Renal function was estimated with creatinine clear- sequent renal failure [1, 2]. Further evidence suggestsance using the Cockcroft formula. Dipstick proteinuria was
that smoking has a similar influence on the progressionassessed on an overnight urine sample by a trained technician.
Results. Adjusted creatinine clearance was higher in current of nephropathies in patients with type 2 diabetes mellitus
smokers than in former smokers and never smokers (100.6 6 [3] and polycystic kidney disease [4].
13.6 vs. 98.8 6 13.9 mL/min/1.73 m2, P , 0.0001, and vs. 98.5 6 However, studies investigating the effect of smoking14.0 mL/min/1.73 m2, P , 0.0001, respectively). This difference
on renal function in subjects without renal disease arewas predominant in men and weak in women, and was associ-
scarce. It was recently reported that effective renal plasmaated with the number of cigarettes smoked daily. The slope of
the projected age-related decline in the creatinine clearance flow was lower in smokers than in nonsmokers [5]. Such
accelerated with age, but it was similar in current smokers, for- findings lead to the hypothesis that smoking would not
mer smokers, and never smokers. Creatinine clearance was
only be a factor involved in the progression of nephropa-associated with a relative risk of proteinuria [for each mL/min/
thies, but could also cause renal dysfunction in subjects1.73 m2, the relative risk was 1.007 (95% CI, 1.000 to 1.015),
P 5 0.056, for 11 or higher proteinuria; and 1.018 (1.004 to without documented renal disease [6, 7]. If true, smoking
1.030), P 5 0.0078, for 21 or higher proteinuria]. Current and could play a prominent role in the development of renal
former smokers had a marked risk of 2 or higher proteinuria
vascular disease, a major cause of end-stage renal dis-[adjusted RR (95% CI), 3.26 (1.66 to 6.80), P 5 0.0009, and
ease, especially in the older population [8, 9]. Neverthe-2.69 (1.24 to 5.99), respectively, P 5 0.013, vs. never smoking],
which was independent of the daily or cumulative cigarette less, large studies demonstrating that smoking is a threat
consumption. for renal function in normal subjects are lacking. Acute
Conclusions. In the general population, smokers do not ex-
smoking or nicotine administration indeed reduced glo-hibit lower creatinine clearance than never smokers. In fact,
merular filtration rate in never smokers or occasionalcreatinine clearance is slightly higher in current smokers at least
in men, even when normotensive and hypertensive subjects are smokers [10, 11], but not in habitual smokers [11]. How-
analyzed separately, but the difference is small, especially in ever, chronic smoking was not associated with impaired
women. This effect seems reversible upon smoking discontinu-
renal function in normal subjects [12]. In addition, theation. Chronic smoking results in a marked risk of irreversible
exact influence of chronic smoking on the physiologicproteinuria that may occur despite moderate smoking.
decline in renal function with age is unclear, since longi-
tudinal studies have not addressed this issue [13].
Finally, it is unknown whether chronic smoking affects
renal function or represents a cause of renal damageKey words: risk factors, progressive renal disease, aging, microalbumi-
nuria, cigarettes and renal function, tobacco in normals. in subjects without pre-existing renal disease; it is also
unclear whether the renal effects of smoking are revers-
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be elucidated—between smoking and the progression of Diabetes mellitus was defined as fasting glucose .7.0
mmol/L or in a patient treated with oral hypoglycemicnephropathies [1].
In the present population-based, cross sectional study, agent or insulin [17].
we assessed whether current and former smokers have
Biochemical measurementsa lower renal function and an increased risk of protein-
uria as compared with never smokers among 28,409 sub- Venous blood samples were collected in the morning
after an overnight fast. Subjects had stopped smokingjects from the general population.
for at least 45 minutes to 1 hour before blood collection.
Total cholesterol [coefficient of variation (CV), 2.0 and
METHODS
2.6% for low and high concentrations, respectively], tri-
Patient selection glycerides (CV, 2.7 and 3.7%), serum glucose (CV, 1.5
and 1.9%), and serum creatinine (Jaffe’s method, CV,From January 1 to June 30, 1998, 28,409 volunteers
(ages 20 to 69) were examined at the Institut Re´gional 2.2 and 3.4%) were measured by standard methods and
assayed on DAX 24 or RA1000 (both Bayer Diagnostics,pour la Sante´ (IRSA, regional institute for health), a
group of nine social medical centers in Western and Cen- Puteaux, France).
Creatinine clearance was estimated using the Cock-tral France (4.5 millions inhabitants, the vast majority
Caucasians). The subjects were screened for a routine croft formula [18] indexed by body surface area.
The presence of proteinuria on the overnight urinemedical and biological checkup provided by their medi-
cal insurance (“Caisse Primaire d’Assurance Maladie”). sample was assessed with dipsticks (Labstixt; Bayer
Diagnostics, Puteaux, France) as negative or trace, 11Most of those screened were individuals basically in good
health and just seeking a general check-up [14]. None (0.30 g/L), 21 (1 g/L), 31 (3 g/L), or 41 (20 g/L). The
reading was performed by a trained technician; negativeof them had a known renal disease.
All of the subjects were interviewed by a trained nurse and trace dipstick-proteinuria were coded as negative as
a standard procedure. Subjects unable to provide a urinewho completed a standardized questionnaire regarding
personal medical history, current treatments, and life- sample, those with dipstick-positive hematuria, and
women under 50 during the menstruation period werestyle behaviors (especially alcohol and smoking habits)
[15]. Complete information regarding smoking habits was excluded from the analysis [1278 out of 28,409 (4.5%)].
available in 27,777 out of 28,409 (97.8%) of the subjects.
Statistical analysisNever smokers were defined as individuals who had
never used tobacco. Current smokers were established Results were given in means 6 standard deviations
and proportions. Unadjusted means were compared us-chronic cigarette smokers, and former smokers were
those who had quit smoking at least one month prior to ing one-way analyses of variance. Linear models were
fitted to adjust for sex, age, and BMI for modeling ofthe examination. Analyses were also performed using a
six-month discontinuation cut-off for the definition of serum creatinine and creatinine clearance [19].
To study the projected age-related decline of creati-former smokers.
A physician recorded clinical parameters, including nine clearance, we considered five age groups: 20 to 29,
30 to 39, 40 to 49, 50 to 59, and 60 to 69. Within eachage, weight, height, systolic and diastolic arterial pres-
sure, and hip and waist circumferences. Body mass index group, a linear model was fitted for each sex and smoking
groups, thus estimating the relationship between age and(BMI) and waist/hip ratio were calculated. Overweight
and obesity were defined as a BMI between 25.0 and creatinine clearance, adjusted for BMI.
Unadjusted relative risks were provided to estimate29.9 kg/m2 and $30 kg/m2, respectively [16].
The arterial pressure was measured with a mercury the effect of smoking on proteinuria. The risk of protein-
uria was also assessed in subgroups of patients: normo-sphyngomanometer on the right arm in the supine posi-
tion after five minutes of rest, with a cuff adapted for tensive and hypertensive subjects, subjects 30 or over (to
rule out orthostatic proteinuria [20]), and nondiabetic sub-arm size. The mean of two measurements was recorded.
Hypertension was defined as a systolic $160 mm Hg jects (to rule out proteinuria related to diabetic nephrop-
athy). A logistic regression model was also used to adjustand/or diastolic arterial pressure $95 mm Hg or a patient
treated with antihypertensive drugs. We did not classify for sex and systolic arterial pressure. Analyses were per-
formed using SAS (SAS institute Inc., Cary, NC, USA).the subjects with an arterial pressure $140/90 mm Hg as
hypertensives, because the measurement of arterial pres-
sure was done only on one occasion. The use of this cut-
RESULTS
off would thus overestimate the true prevalence of hyper-
Characteristics of the populationtension. However, the $140/90 mm Hg cut-off was also
used in the analyses. Complete information regarding As described in Table 1 (unadjusted values), men rep-
resented 44.5% of the population. Overall, 8.9% werearterial pressure was available in 98.0% of the population.
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Table 1. Baseline characteristics of the population (unadjusted values)
Men Women
All Never Current Former Never Current Former
subjects smokers smokers smokers smokers smokers smokers
Number 28409 4958 4500 2959 10193 3673 1494
Age years 41.4612.3 42.5612.3 37.4611.2 46.8611.0 44.0612.2 33.669.9 39.5610.5
Number of cigarettes per day — — 14.568.7 19.1611.8 — 12.668.1 14.6610.3
Duration of smoking years — — 19.4610.7 17.769.9 — 15.468.7 12.868.4
Number of pack years — — 14.3612.7 17.3615.8 — 10.2610.3 9.7610.5
Duration of smoking
discontinuation years — — — 11.068.7 — — 8.467.6
Alcohol drinkers % 43.0 61.4 48.5 68.7 32.2 25.5 32.2
intake g/day 22.9621.5 24.8619.5 31.4626.4 29.7624.5 15.2614.3 14.6617.0 15.8615.9
Body mass index (BMI) kg/m2 24.464.4 25.063.6 24.163.8 26.363.7 24.464.8 22.764.5 24.064.6
BMI 25–29.9 % 28.1 37.7 29.0 47.2 23.3 15.3 20.1
BMI $ 30.0 % 10.2 8.4 7.2 14.2 12.3 7.2 10.4
Waist/hip ratio 0.8460.10 0.9160.07 0.9060.08 0.9360.07 0.7960.08 0.7860.07 0.7860.07
Systolic arterial pressure mm Hg 128.0614.5 132.0613.5 130.6613.7 134.8614.8 126.3614.4 120.6612.4 122.9613.4
Diastolic arterial pressure mm Hg 76.7610.0 79.369.7 77.869.9 80.969.9 75.869.7 72.069.3 74.369.5
anti-hypertensive treatment % 2.9 3.0 1.9 5.6 3.5 1.0 1.6
hypertensives % 8.9 11.3 8.6 16.6 8.3 3.0 4.9
Serum creatinine lmol/L 75.2612.1 84.4610.2 81.669.9 84.4610.3 68.769.0 68.068.7 68.868.8
Fasting glucose mmol/L 5.2360.94 5.3860.82 5.3461.00 5.6360.11 5.1560.88 4.9260.70 5.0860.84
Total cholesterol mmol/L 5.4861.05 5.5461.03 5.4461.16 5.7761.01 5.4860.99 5.1260.97 5.3160.94
Triglycerides mmol/L 1.1860.93 1.2361.10 1.4761.25 1.5361.08 1.0060.66 1.0360.66 1.0160.65
hypertensive, and 28.1% and 10.2% were overweight between current smokers and never smokers was marked
and obese, respectively. Forty-three percent of the sub- in men and smaller in women; the difference in creatinine
jects were habitual alcohol drinkers. Among habitual al- clearance remained significant when normotensives
cohol drinkers, the mean alcohol intake was 22.9 g/day. (100.9 6 13.7 vs. 98.9 6 14.2 mL/min/1.73 m2, respec-
Current and former smokers represented 29.5% and tively, P , 0.0001) and hypertensives (98.0 6 15.4 vs.
16.0% of the population, respectively. 94.7 6 12.8 mL/min/1.73 m2, respectively, P , 0.0001)
The sex ratio was different among current smokers were analyzed separately. The results were unchanged
(55.1% men), former smokers (66.4% men), and never when different cut-offs for hypertension and for the defi-
smokers (32.7% men). Current smokers were younger, nition of former smokers were used, and when the sub-
had lower BMI, and lower systolic and diastolic arterial
jects with antihypertensive medications were excludedpressure than never smokers and former smokers in both
from the analysis.men and women. In men, triglycerides were higher in
In current smokers, creatinine clearance was signifi-current and former smokers than in never smokers.
cantly associated with the number of cigarettes smoked
Effect of smoking on renal function per day (estimate: 11.2 6 1.7 mL/min/1.73 m2 per for
10 cigarettes smoking, P , 0.0001), but not with the dura-Using unadjusted values, creatinine clearance was
tion of smoking (estimate: 10.03 6 3.1 mL/min/1.73 m2higher in current smokers than in former and never smok-
ers (104.5 6 18.1, 97.9 6 18.2, and 97.7 6 18.2 mL/min/ per year, P 5 0.36).
1.73 m2, respectively, both P , 0.0001 vs. never smokers
and former smokers). However, the baseline characteris- Effect of smoking on the decline in renal function
tics of never smokers, current smokers, and former with age
smokers were markedly different, especially regarding As described in Figure 1A (men) and B (women), the
sex ratio, age, and BMI (Table 1); it was thus necessary projected age-related decline of the creatinine clearance
to adjust renal function for these confounding variables.
appeared roughly similar regardless of the smoking hab-The results were presented separately for men and
its; however, the creatinine clearance was usually higherwomen because an interaction between sex and smoking
in current than in former smokers and never smokers,was detected when modeling serum creatinine and creati-
at least in men.nine clearance.
As shown in Table 3 (adjusted slopes), the projectedAs shown in Table 2 (adjusted means), serum creati-
decline of the creatinine clearance was not linear, but itnine was lower and creatinine clearance higher in current
accelerated with advancing age, regardless of the smok-smokers than in former smokers and never smokers. The
difference in serum creatinine and creatinine clearance ing status.
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Table 2. Renal function in never smokers, current smokers and former smokers (adjusted values)
All subjects Men Women
Never Current Former Never Current Former Never Current Former
smokers smokers smokers smokers smokers smokers smokers smokers smokers
Number 15151 8173 4453 4958 4500 2959 10190 3673 1491
Serum creatinine lmol/L 76.6610.2 74.969.9 76.6610.1 84.469.5 81.669.6 84.469.6 68.869.6 68.169.8 68.869.5
P values vs. never smoker ,0.0001 0.97 ,0.0001 0.86 0.0008 0.92
P value vs. current smoker ,0.0001 ,0.0001 ,0.0001
Creatinine clearance
mL/min/1.73 m2 98.5614.0 100.6613.6 98.8613.9 98.2613.1 101.5613.2 98.8613.3 98.9613.2 99.7613.5 99.4613.1
P values vs. never smoker ,0.0001 0.24 ,0.0001 0.89 0.001 0.16
P value vs. current smoker ,0.0001 ,0.0001 0.42
Values are adjusted for sex, age and body mass index.
Fig. 1. Age-related decline in creatinine clear-
ance in relationship to smoking habits in men
(A) and women (B) (unadjusted values). Sym-
bols are: (thin line) never smokers; (thick line)
current smokers; (dotted line) former smokers.
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Table 3. Slopes of the decline of creatinine clearance with advancing age
Men Women
Never Current Former Never Current Former
Age group smokers smokers smokers smokers smokers smokers
20–29 21.2060.15 20.6860.12 20.7960.35 20.4360.14 20.7660.14 20.9560.38
(872) (1299) (205) (1562) (1456) (276)
30–39 20.8660.12 20.8260.13 20.8160.18 21.2260.12 20.9060.14 21.4060.26
(1145) (1294) (562) (1807) (1168) (479)
40–49 20.9660.11 21.0460.13 21.0560.13 20.9960.08 21.0560.17 21.0560.21
(1410) (1128) (959) (3224) (753) (449)
50–59 21.1360.13 21.3060.19 21.0460.15 21.1960.08 20.4260.30 20.9360.26
(962) (549) (783) (2337) (207) (209)
60–69 21.3260.19 21.3160.37 21.1160.21 21.3660.13 21.0460.65 20.6060.47
(521) (172) (424) (1132) (37) (58)
Results are expressed as slope estimate 6 SD (sample size) in mL/min/year, adjusted for body mass index. None of the differences between current smokers,
former smokers and never smokers were significant.
Table 4. Relative risk of proteinuria in the general population
11 or higher proteinuria 21 or higher proteinuria
Odds ratio 95% CI P values Odds ratio 95% CI P values
Model 1
Systolic arterial pressure mm Hg 1.014 1.004–1.023 0.0036 1.022 1.005–1.037 0.0074
Smoking (either past or current) 2.157 1.568–3.004 0.0001 3.035 1.615–6.141 0.001
Sex (women vs. men) 0.425 0.299–0.597 0.0001 0.302 0.139–0.598 0.0012
Model 2
Systolic arterial pressure mm Hg 1.014 1.005–1.023 0.0025 1.022 1.005–1.037 0.0054
Smoking (either past or current) 2.085 1.513–2.908 0.0001 2.797 1.487–5.664 0.0024
Creatinine clearance mL/min/1.73 m2 1.007 1.000–1.015 0.0562 1.018 1.004–1.030 0.0078
Sex (women vs. men) 0.426 0.300–0.597 0.0001 0.293 0.135–0.582 0.0009
Effect of smoking on proteinuria Similar relative risk values were observed in subjects
30 or older and in nondiabetic subjects.Dipstick-positive proteinuria was present in 0.70% of
Finally, smoking (whether current or past smoking)the population (11, 0.50%; 21, 0.17%; 31, 0.03%; 41, 0);
represented the most powerful risk of proteinuria amongnone of them had concomitant hematuria. The percentage
men and women, even when normotensive and hyperten-of subjects dipstick-positive proteinuria was higher in
sive subjects were analyzed separately, even when a dif-hypertensives than in normotensives (1.63 vs. 0.56%, P ,
ferent cut-off for hypertension was used (Table 5).0.001) and in men than in women (1.13 vs. 0.35%, P ,
Of note, the number of cigarettes smoked per day0.001).
(15.0 6 9.9 vs. 16.2 6 9.7 cigarettes, P 5 0.09) and theUsing a logistic procedure, current smoking and past
duration of smoking (17.2 6 9.9 vs. 17.3 6 10.7 years,smoking were associated with similar risks of proteinuria
P 5 0.85) were comparable in smokers with proteinuria[RR, 2.438 (1.733 to 3.455), P 5 0.0001, and 1.707 (1.117
and in those without.to 2.584), P 5 0.01, respectively, as compared with never
smokers for 11 or higher proteinuria; RR, 3.263 (1.657
to 6.804), P 5 0.0009, and 2.691 (1.235 to 5.993), P 5
DISCUSSION0.01, for 21 or higher proteinuria]. Similar findings were
In the present cross sectional study conducted in overobserved when a different cut-off was used for the defi-
28,000 subjects, we found that current smokers did notnition of former smokers.
exhibit lower, but higher creatinine clearance than neverNo interaction was found between gender and smok-
smokers, at least in men. This increase in creatinine clear-ing, indicating that the increase in the prevalence of
ance was related to the daily cigarette consumption andproteinuria associated with smoking was similar in men
was not observed in former smokers. In addition, ele-and women.
vated creatinine clearance itself was a risk for protein-As shown in Table 4, the adjusted risk of 11 and
uria. Finally, both current and former smokers had ahigher or 21 or higher proteinuria was related to systolic
greater risk of proteinuria than never smokers.arterial pressure, gender, smoking habit, and creatinine
clearance. The unadjusted creatinine clearance in current smokers
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Table 5. Relative risk of 11 or higher proteinuria in normotensive and hypertensive subjects
Normotensive subjects Hypertensive subjects
Odds ratio 95% CI P values Odds ratio 95% CI P values
Systolic arterial pressure mm Hg 0.994 0.978–1.009 0.4132 1.009 0.991–1.027 0.3181
Smoking (either past or current) 2.033 1.429–2.934 0.0001 2.355 1.136–5.315 0.0280
Sex (women vs. men) 0.419 0.285–0.607 0.0001 0.237 0.068–0.639 0.0100
exceeded that of never smokers by 6.8 mL/min/1.73 m2. such a modest glomerular hyperfiltration? It was demon-
strated in animal models that hyperfiltration is associatedThe difference remained significant for men and women
when adjusted creatinine clearance values were consid- with increased intraglomerular capillary pressure, which
results in proteinuria reflecting glomerulosclerosis le-ered, even when normotensives and hypertensives were
analyzed separately. sions [24]. Hyperfiltration was documented in humans
after uninephrectomy and uncontrolled diabetes melli-Does this higher creatinine clearance in smokers mean
a better renal function? It is possible that this increase tus; it may constitute a major mechanism of progression
of nephropathies [24, 25] and renal aging [24, 26]. Itin creatinine clearance reflects a direct effect of smoking
on tubular creatinine secretion or is a consequence of usually considered that hyperfiltration may be harmful
only when creatinine clearance largely exceeds the nor-the interference between smoking and the estimation of
creatinine using the method of Jaffe. However, several mal range. The most widely recognized situation is the
early stage of diabetic nephropathy. However, in thepieces of evidence suggest differently. In a previous study
performed in a small number of subjects, smokers and present investigation, even small increases in creatinine
clearance represented a risk for proteinuria. A 5 mL/min/nonsmokers exhibited similar DTPA clearance/creati-
nine clearance ratio, and nicotine administration did not 1.73 m2 increment in creatinine clearance was associated
with a 9.3% increased risk of 21 or greater proteinuria.alter this ratio, suggesting that neither smoking nor nico-
tine modify tubular handling of creatinine [11]. The pres- However, the age-related decline in renal function was
similar, regardless of smoking habits, and the slope ofent results are also in agreement with the increase in
renal function in smokers as compared with nonsmokers, this decline was comparable in current smokers, former
smokers, and never smokers. Our results indicate thatwhether it was assessed with serum creatinine levels [21]
or creatinine clearances on a 24-hour urine collection [12] smoking may be associated with a reversible chronic but
modest hyperfiltration, which seems to have little or noin normal subjects. In the latter study, the use of creati-
nine clearances on a 24-hour urine collection would con- consequence on the renal function in most normal sub-
jects, but could create renal lesions resulting in protein-siderably mitigate (or eliminate) any interference between
smoking and the estimation of creatinine using Jaffe’s uria. This observation must be interpreted with caution
and confirmed by longitudinal studies focused on renalmethod [12]. Furthermore, the difference in creatinine
clearance was predominant in men but much weaker in function. It is also important to note that no randomiza-
tion was performed in the selection of the population,women. It is therefore necessary to assume that the effect
of smoking (if any) on tubular creatinine secretion may which could create a selection bias.
The mechanism of this higher renal function in currentbe modulated by gender. However, other methodologi-
cal limitations must be acknowledged: The Cockcroft smokers is unknown. It is widely accepted that excessive
protein intake is associated with increased renal function.formula may be misleading in particular in obese subjects
and the elderly, and Jaffe’s method, although largely However, a higher protein intake in smokers is unlikely
since a similar or lower protein intake in smokers asused, is not entirely specific of creatinine measurement.
It is thus important to confirm our findings using a compared with nonsmokers was found in a previous
study from our group (abstract; Vol et al, Proceedingsbetter method for renal function measurement. In effect,
using a precise and validated method of glomerular filtra- of the 3rd European Congress on Obesity, 1991, Nice,
France); importantly, this study was conducted in thetion rate assessment (51Cr-EDTA clearance), two separate
investigations in diabetics without overt nephropathy same medical centers and included 48,000 subjects very
similar to those included in the present investigation.showed that smokers had greater glomerular filtration
rates than nonsmokers [22, 23]. Together with these re- Similar findings were reported in most epidemiological
studies [27]. Interestingly, it was recently reported thatsults, the present findings suggest that the lower serum
creatinine and higher creatinine clearance in smokers acute oral administration of nicotine caused a rise in
urinary cyclic guanosine monophosphate (GMP) [11],indicate a higher renal function, that is, a small degree
of glomerular hyperfiltration. a marker of the interaction between nitric oxide/atrial
natriuretic peptide and effector cells [28]. Since releaseWhat would be the likely long-term consequences of
Halimi et al: Renal effects of smoking in normal subjects 1291
of nitric oxide and atrial natriuretic peptide causes con- of increased cardiovascular risk is unclear [32, 37, 38].
However, the result of the logistic regression shows thatsistent renal vasodilation associated with increased uri-
nary excretion of cGMP [28], it is possible that these smoking was still significantly associated with proteinuria
when creatinine clearance was in the model, suggestingvasodilatory compounds repeatedly released after each
cigarette smoked eventually cause chronic glomerular that the effect of smoking was related to other factors
as well such as repeated arterial pressure rise after eachhyperfiltration. Admittedly, hormones such as vasopres-
sin or adrenocorticoid hormone may also play a role cigarette smoked and release of vasoconstrictor sub-
stances such as endothelin, which may be an important[29]. Further studies are needed to address this issue.
In the present investigation, the prevalence of dipstick- modulator of the progression of renal diseases [26]. Fur-
ther studies addressing the role of other parameters (es-positive proteinuria was around two to three times higher
in current smokers than never smokers. The risk of pro- pecially the smoking-induced endothelin release) on the
progression of renal diseases are needed [7, 25, 39].teinuria remained virtually unchanged when diabetic
subjects were excluded from the analysis and when nor- In conclusion, chronic smoking is not associated with
lower creatinine clearance as compared with formermotensive and hypertensive subjects were analyzed sepa-
rately: This indicates that the effect of smoking was not smokers and never smokers in the general population.
In fact, creatinine clearance was higher in current smok-attributable to inclusion of special groups at risk for
proteinuria. Orthostatic proteinuria, which has a benign ers at least in men. Whether this modest increase in
creatinine clearance may play a role in the deleteriousprognosis [20], is very unlikely since the marked risk
of dipstick-positive proteinuria associated with smoking influence of smoking on the progression of pre-existing
nephropathies is speculative; however, a small increaseremained unchanged when subjects under 30 were ex-
cluded from the analysis. Of note, the risk of proteinuria in creatinine clearance itself was associated a risk of
proteinuria in our population. Finally, chronic smokingwas unrelated to the exposure to smoking: Even moder-
ate smoking may be a risk factor for proteinuria. is also associated with a marked risk of developing a
proteinuria, which seems irreversible and unrelated toThe exact nature of the urinary proteins detected by
dipsticks is unclear in the absence of quantitative mea- the overall exposure to smoking, that is, may occur de-
spite moderate smoking.surement, but is probably mainly albumin. Dipsticks are
more sensitive to albumin than to other proteins con-
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